31999.01.01
|
ABACAVIR+LAMIVUDINE/MYLAN PHARMA F.C.TAB (600+300)MG/TAB BT x 30 (30x1) TABS σε BLISTER (PVC/PVDC/AL)
|
|
97,33 |
111,88 |
137,57 |
Mylan Healthcare Ireland Ltd
|
32752.01.03
|
ABEVMY C/S.SOL.IN 25MG/ML 1 VIAL X 16 ML
|
|
570,82 |
634,87 |
720,07 |
Mylan Healthcare Ireland Ltd
|
32752.01.01
|
ABEVMY C/S.SOL.IN 25MG/ML 1 VIAL X 4 ML
|
|
147,17 |
169,16 |
204,41 |
Mylan Healthcare Ireland Ltd
|
32869.01.06
|
ABIRATERONE MYLAN F.C.TAB 500MG/TAB 60 ΔΙΣΚΙΑ ΣΕ BLISTERS (ALU-PVC/PE/PVDC)
|
|
1.462,20 |
1.626,27 |
1.788,50 |
Mylan Healthcare Ireland Ltd
|
32361.01.11
|
APIXABAN/MYLAN F.C.TAB 2.5MG/TAB BT X 60 X 1 TAB ΣΕ UNIT-DOSE ALU-PVC/PVDC BLISTER
|
|
30,06 |
34,55 |
47,62 |
Mylan Healthcare Ireland Ltd
|
32361.02.13
|
APIXABAN/MYLAN F.C.TAB 5MG/TAB BT X 60 X 1 TAB ΣΕ UNIT-DOSE ALU-PVC/PVDC BLISTER
|
|
30,08 |
34,57 |
47,64 |
Mylan Healthcare Ireland Ltd
|
25673.02.03
|
ARIXTRA INJ.SOL 1,5MG/0,3ML PF.SYR BTX10 PF.SYR.
|
|
22,34 |
25,67 |
35,37 |
Mylan Healthcare Ireland Ltd
|
25673.05.03
|
ARIXTRA INJ.SOL 10MG/0,8ML BTX10PF.SYR
|
|
103,51 |
118,98 |
146,30 |
Mylan Healthcare Ireland Ltd
|
25673.01.03
|
ARIXTRA INJ.SOL 2,5MG/0,5ML PF.SYR BTX10PF.SYR.
|
|
29,04 |
33,38 |
45,99 |
Mylan Healthcare Ireland Ltd
|
25673.04.03
|
ARIXTRA INJ.SOL 7,5MG/0,6ML BTX10PF.SYR
|
|
94,15 |
108,22 |
133,07 |
Mylan Healthcare Ireland Ltd
|
31502.01.06
|
ATORVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx28
|
|
4,63 |
5,32 |
7,34 |
Mylan Healthcare Ireland Ltd
|
31502.02.06
|
ATORVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx28
|
|
5,06 |
5,81 |
8,00 |
Mylan Healthcare Ireland Ltd
|
31502.03.06
|
ATORVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx28
|
|
5,06 |
5,81 |
8,00 |
Mylan Healthcare Ireland Ltd
|
32409.01.01
|
AZACITIDINE MYLAN PD.INJ.SUS 25MG/ML 1 vial x 100 mg
|
|
145,61 |
167,37 |
202,25 |
Mylan Healthcare Ireland Ltd
|
31962.02.01
|
BORTEZOMIB/MYLAN PD.INJ.SOL 3.5MG/VIAL BT x 1 VIAL (6ML)x 1 MG
|
|
384,60 |
427,75 |
494,22 |
Mylan Healthcare Ireland Ltd
|
31035.02.03
|
CAPECITABINE/MYLAN F.C.TAB 500MG/TAB BTx1 tab x 120 blisters (Al/PVC/PE/PVDC)-unit dose
|
|
71,76 |
82,48 |
104,92 |
Mylan Healthcare Ireland Ltd
|
31014.02.03
|
CARVEDILOL/MYLAN F.C.TAB 12,5MG/TAB BTx28 (2 BLIST x14)
|
|
3,00 |
3,45 |
4,75 |
Mylan Healthcare Ireland Ltd
|
31014.03.03
|
CARVEDILOL/MYLAN F.C.TAB 25MG/TAB ΒΤx28 (2 BLIST x14)
|
|
3,34 |
3,84 |
5,29 |
Mylan Healthcare Ireland Ltd
|
31014.01.03
|
CARVEDILOL/MYLAN F.C.TAB 6,25MG/TAB BTx28 (2 BLIST x14)
|
|
1,42 |
1,64 |
2,26 |
Mylan Healthcare Ireland Ltd
|
33062.01.02
|
DIMETHYL FUMARATE MYLAN GR.CAP 120MG/CAP 14 X 1 ΚΑΨΑΚΙΟ (ΜΟΝΑΔΑ ΔΟΣΗΣ) ΣΕ BLISTERS PVC/PE/PVDC/ALU
|
|
54,46 |
62,60 |
79,63 |
Mylan Healthcare Ireland Ltd
|
33062.02.02
|
DIMETHYL FUMARATE MYLAN GR.CAP 240MG/CAP 56 X 1 ΚΑΨΑΚΙΟ (ΜΟΝΑΔΑ ΔΟΣΗΣ) ΣΕ BLISTERS PVC/PE/PVDC/ALU
|
|
408,02 |
453,81 |
524,33 |
Mylan Healthcare Ireland Ltd
|
31059.02.02
|
DONEPEZIL/MYLAN F.C.TAB 10MG/TAB BT x 28 (σε PVDC BLISTER) (σε PVDC BLISTER)
|
|
12,89 |
14,81 |
20,41 |
Mylan Healthcare Ireland Ltd
|
31059.01.03
|
DONEPEZIL/MYLAN F.C.TAB 5MG/TAB BT x 28 (σε PVDC BLISTER) (σε PVDC BLISTER)
|
|
8,99 |
10,33 |
14,24 |
Mylan Healthcare Ireland Ltd
|
31442.01.02
|
ERLOTINIB/MYLAN F.C.TAB 100MG/TAB BTx(30x1) tabs σε Aluminium - OPA/Alu/PVC berforated blisters unit dose
|
|
654,19 |
727,59 |
821,37 |
Mylan Healthcare Ireland Ltd
|
31368.01.02
|
ESCITALOPRAM/MYLAN F.C.TAB 10MG/TAB BT x 14 TABS σε blisters (PVC/PVdC/Alu) σε blisters (PVC/PVdC/Alu)
|
|
2,62 |
3,01 |
4,14 |
Mylan Healthcare Ireland Ltd
|
31368.01.05
|
ESCITALOPRAM/MYLAN F.C.TAB 10MG/TAB BT x 30 TABS σε blisters (PVC/PVdC/Alu) σε blisters (PVC/PVdC/Alu)
|
|
4,93 |
5,66 |
7,80 |
Mylan Healthcare Ireland Ltd
|
31368.02.02
|
ESCITALOPRAM/MYLAN F.C.TAB 20MG/TAB BT x 14 TABS σε blisters (PVC/PVdC/Alu) σε blisters (PVC/PVdC/Alu)
|
|
4,96 |
5,71 |
7,87 |
Mylan Healthcare Ireland Ltd
|
31368.02.05
|
ESCITALOPRAM/MYLAN F.C.TAB 20MG/TAB BT x 30 TABS σε blisters (PVC/PVdC/Alu) σε blisters (PVC/PVdC/Alu)
|
|
9,36 |
10,76 |
14,83 |
Mylan Healthcare Ireland Ltd
|
30761.01.06
|
EZETIMIBE+SIMVASTATIN/MYLAN TAB (10+10)MG/TAB BTx(28 x 1) tabs σε blister (unit dose)
|
|
13,57 |
15,60 |
21,50 |
Mylan Healthcare Ireland Ltd
|
30761.02.07
|
EZETIMIBE+SIMVASTATIN/MYLAN TAB (10+20)MG/TAB BTx(28 x 1) tabs ( PVC/PVDC-Alu blister-unit dose)
|
|
11,43 |
13,14 |
18,10 |
Mylan Healthcare Ireland Ltd
|
30761.03.07
|
EZETIMIBE+SIMVASTATIN/MYLAN TAB (10+40)MG/TAB BTx(28 x 1) tabs ( PVC/PVDC-Alu blister-unit dose)
|
|
12,06 |
13,87 |
19,11 |
Mylan Healthcare Ireland Ltd
|
32856.01.18
|
FINGOLIMOD MYLAN CAPS 0.5MG/CAP 28 ΚΑΨΑΚΙΑ - ΣΕ BLISTERS PVC/PE/PVDC/ALU
|
|
692,12 |
769,78 |
869,00 |
Mylan Healthcare Ireland Ltd
|
31058.01.07
|
FLUOXETINE/MYLAN CAPS 20MG/CAP BTx28 (BLISTER)
|
|
4,53 |
5,20 |
7,17 |
Mylan Healthcare Ireland Ltd
|
30946.01.03
|
FUSIDIC ACID+BETAMETHASONE VALERATE/MYLAN CREAM (20+1)MG/G BTx30G
|
|
4,25 |
4,91 |
7,03 |
Mylan Healthcare Ireland Ltd
|
31405.01.02
|
GLATIRAMER/MYLAN INJ.SO.PFS 40MG/1ML PF.SYR. BTx12 (PF.SYR x1ML)
|
|
424,90 |
472,57 |
546,01 |
Mylan Healthcare Ireland Ltd
|
31192.01.03
|
IMATINIB/MYLAN F.C.TAB 100MG/TAB BTx60 (6x1) σε PVC/PE/PVDC/ALU PERFORATED UNIT-DOSE BLISTERS
|
|
174,29 |
200,34 |
237,84 |
Mylan Healthcare Ireland Ltd
|
31192.02.03
|
IMATINIB/MYLAN F.C.TAB 400MG/TAB BTx30 (30x1) σε PVC/PE/PVDC/ALU PERFORATED UNIT-DOSE BLISTERS
|
|
436,92 |
485,94 |
561,45 |
Mylan Healthcare Ireland Ltd
|
32640.04.02
|
LENALIDOMIDE MYLAN CAPS 10.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
1.840,20 |
2.046,69 |
2.234,58 |
Mylan Healthcare Ireland Ltd
|
32640.05.02
|
LENALIDOMIDE MYLAN CAPS 15.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
1.939,95 |
2.157,63 |
2.355,70 |
Mylan Healthcare Ireland Ltd
|
32640.01.03
|
LENALIDOMIDE MYLAN CAPS 2.5MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
941,34 |
1.046,96 |
1.165,27 |
Mylan Healthcare Ireland Ltd
|
32640.06.03
|
LENALIDOMIDE MYLAN CAPS 20.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
2.455,66 |
2.731,20 |
2.967,45 |
Mylan Healthcare Ireland Ltd
|
32640.07.03
|
LENALIDOMIDE MYLAN CAPS 25.0MG/CAP BT x 21 x 1καψάκια - μονάδα δλοσης σε BLISTERS PVC/ACLAR/ αλουμίνιο
|
|
2.272,82 |
2.527,85 |
2.746,51 |
Mylan Healthcare Ireland Ltd
|
32640.02.02
|
LENALIDOMIDE MYLAN CAPS 5.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
1.882,67 |
2.093,91 |
2.286,13 |
Mylan Healthcare Ireland Ltd
|
32640.03.03
|
LENALIDOMIDE MYLAN CAPS 7.5MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
|
1.380,15 |
1.535,01 |
1.688,12 |
Mylan Healthcare Ireland Ltd
|
31037.03.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (100+25+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,47 |
9,73 |
13,41 |
Mylan Healthcare Ireland Ltd
|
31037.04.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (125+31,25+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,02 |
9,22 |
12,71 |
Mylan Healthcare Ireland Ltd
|
31037.05.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (150+37,5+200)MG/TAB BTx30 (HDPE Bottle)
|
|
9,31 |
10,70 |
14,74 |
Mylan Healthcare Ireland Ltd
|
31037.06.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (200+50+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,61 |
9,89 |
13,63 |
Mylan Healthcare Ireland Ltd
|
31037.01.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (50+12.5+200)MG/TAB BTx30 (HDPE Bottle)
|
|
8,61 |
9,89 |
13,63 |
Mylan Healthcare Ireland Ltd
|
31037.02.03
|
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN F.C.TAB (75+18.75+200)MG/TAB BTx30 (HDPE Bottle)
|
|
9,16 |
10,53 |
14,51 |
Mylan Healthcare Ireland Ltd
|
31015.01.05
|
MIRTAZAPINE/MYLAN F.C.TAB 30MG/TAB BTx30 ΣΕ PVDC COATED PVC BLISTER STRIPS WITH ALUMINIUM FOIL LIDDING
|
|
4,94 |
5,68 |
7,82 |
Mylan Healthcare Ireland Ltd
|
31015.02.05
|
MIRTAZAPINE/MYLAN F.C.TAB 45MG/TAB BTx30 ΣΕ PVDC COATED PVC BLISTER STRIPS WITH ALUMINIUM FOIL LIDDING
|
|
6,73 |
7,73 |
10,65 |
Mylan Healthcare Ireland Ltd
|
31029.02.02
|
MOXONIDINE/MYLAN F.C.TAB 300MCG/TAB BTx 28 (σε BLISTERS)
|
|
3,56 |
4,09 |
5,64 |
Mylan Healthcare Ireland Ltd
|
32451.02.01
|
NEPEXTO INJ.SOL 50 MG/1ML 4 PF. SYRS x 1 ML
|
|
414,59 |
461,11 |
532,77 |
Mylan Healthcare Ireland Ltd
|
32451.02.03
|
NEPEXTO INJ.SOL 50 MG/1ML 4 PF.PEN x 1 ML
|
|
414,59 |
461,11 |
532,77 |
Mylan Healthcare Ireland Ltd
|
31525.01.02
|
OLMEDIPIN F.C.TAB (20+5)MG/TAB 1 BTx28 TABS σε BLISTER PVC/Alu/OPA-Alu
|
|
6,30 |
7,24 |
9,97 |
Mylan Healthcare Ireland Ltd
|
31525.03.02
|
OLMEDIPIN F.C.TAB (40+10)MG/TAB 1 BTx28 TABS σε BLISTER PVC/Alu/OPA-Alu
|
|
6,94 |
7,97 |
10,98 |
Mylan Healthcare Ireland Ltd
|
31525.02.02
|
OLMEDIPIN F.C.TAB (40+5)MG/TAB 1 BTx28 TABS σε BLISTER PVC/Alu/OPA-Alu
|
|
6,41 |
7,36 |
10,14 |
Mylan Healthcare Ireland Ltd
|
32043.01.01
|
OLMEDIPIN PLUS F.C.TAB (20+5+12.5)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
7,48 |
8,60 |
11,85 |
Mylan Healthcare Ireland Ltd
|
32043.04.01
|
OLMEDIPIN PLUS F.C.TAB (40+10+12.5)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
7,38 |
8,49 |
11,70 |
Mylan Healthcare Ireland Ltd
|
32043.05.01
|
OLMEDIPIN PLUS F.C.TAB (40+10+25.0)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
7,52 |
8,64 |
11,90 |
Mylan Healthcare Ireland Ltd
|
32043.02.01
|
OLMEDIPIN PLUS F.C.TAB (40+5+12.5)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
7,48 |
8,60 |
11,85 |
Mylan Healthcare Ireland Ltd
|
32043.03.01
|
OLMEDIPIN PLUS F.C.TAB (40+5+25.0)MG/TAB BTx28 TABS σε κυψέλες ALU/ALU
|
|
7,60 |
8,74 |
12,04 |
Mylan Healthcare Ireland Ltd
|
30576.01.02
|
OLMESARTAN/MYLAN F.C.TAB 10MG/TAB BTx28 (lamιnatedpolyamide/aluminium/polyvinyl chloride/aluminium Blister)
|
|
3,59 |
4,12 |
5,68 |
Mylan Healthcare Ireland Ltd
|
30576.02.02
|
OLMESARTAN/MYLAN F.C.TAB 20MG/TAB BTx28 (lamιnatedpolyamide/aluminium/polyvinyl chloride/aluminium Blister)
|
|
3,97 |
4,56 |
6,29 |
Mylan Healthcare Ireland Ltd
|
30576.03.02
|
OLMESARTAN/MYLAN F.C.TAB 40MG/TAB BTx28 (lamιnatedpolyamide/aluminium/polyvinyl chloride/aluminium Blister)
|
|
4,05 |
4,66 |
6,42 |
Mylan Healthcare Ireland Ltd
|
32143.01.02
|
PEMETREXED/MYLAN C/S.SOL.IN 25MG/ML 1 Vial x20 ml
|
|
386,80 |
430,20 |
497,06 |
Mylan Healthcare Ireland Ltd
|
32143.01.01
|
PEMETREXED/MYLAN C/S.SOL.IN 25MG/ML 1Vial x 4ML
|
|
83,20 |
95,64 |
121,66 |
Mylan Healthcare Ireland Ltd
|
32946.02.04
|
RIVAROXABAN MYLAN F.C.TAB 10MG/TAB BT X 10 X 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
9,71 |
11,16 |
15,38 |
Mylan Healthcare Ireland Ltd
|
32946.03.08
|
RIVAROXABAN MYLAN F.C.TAB 15MG/TAB BT X 28 Χ 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
27,33 |
31,42 |
43,30 |
Mylan Healthcare Ireland Ltd
|
32946.01.09
|
RIVAROXABAN MYLAN F.C.TAB 2.5MG/TAB BT X 56 Χ 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
28,56 |
32,82 |
45,23 |
Mylan Healthcare Ireland Ltd
|
32946.04.07
|
RIVAROXABAN MYLAN F.C.TAB 20MG/TAB BT X 28 Χ 1 ΔΙΣΚΙΑ - ΜΟΝΑΔΑ ΔΟΣΗΣ ΣΕ BLISTERS PVC/PVDC/ΑΛΟΥΜΙΝΙΟ
|
|
27,33 |
31,42 |
43,30 |
Mylan Healthcare Ireland Ltd
|
31120.02.01
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister) (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
3,92 |
4,51 |
6,21 |
Mylan Healthcare Ireland Ltd
|
31120.02.16
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
3,92 |
4,51 |
6,21 |
Mylan Healthcare Ireland Ltd
|
31120.02.03
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
7,84 |
9,01 |
12,41 |
Mylan Healthcare Ireland Ltd
|
31120.02.18
|
ROSUVASTATIN/MYLAN F.C.TAB 10MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
7,84 |
9,01 |
12,41 |
Mylan Healthcare Ireland Ltd
|
31120.03.01
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister) (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
5,52 |
6,35 |
8,76 |
Mylan Healthcare Ireland Ltd
|
31120.03.16
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
5,52 |
6,35 |
8,76 |
Mylan Healthcare Ireland Ltd
|
31120.03.03
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
11,04 |
12,69 |
17,49 |
Mylan Healthcare Ireland Ltd
|
31120.03.18
|
ROSUVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
11,04 |
12,69 |
17,49 |
Mylan Healthcare Ireland Ltd
|
31120.04.01
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister) (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
6,89 |
7,92 |
10,92 |
Mylan Healthcare Ireland Ltd
|
31120.04.16
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
6,89 |
7,92 |
10,92 |
Mylan Healthcare Ireland Ltd
|
31120.04.03
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister) (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
13,71 |
15,76 |
21,72 |
Mylan Healthcare Ireland Ltd
|
31120.04.18
|
ROSUVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
13,71 |
15,76 |
21,72 |
Mylan Healthcare Ireland Ltd
|
31120.01.01
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx14 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister) (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
1,81 |
2,08 |
2,86 |
Mylan Healthcare Ireland Ltd
|
31120.01.16
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx14 OPA/aluminium/PVC-aluminium blisters
|
|
1,81 |
2,08 |
2,86 |
Mylan Healthcare Ireland Ltd
|
31120.01.03
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx28 (Polyamide/Al/LDPE DESICCANT-HDPE/Al/ blister)
|
|
3,41 |
3,93 |
5,41 |
Mylan Healthcare Ireland Ltd
|
31120.01.18
|
ROSUVASTATIN/MYLAN F.C.TAB 5MG/TAB BTx28 OPA/aluminium/PVC-aluminium blisters
|
|
3,42 |
3,93 |
5,42 |
Mylan Healthcare Ireland Ltd
|
31028.02.05
|
SERTRALINE/MYLAN F.C.TAB 100MG/TAB BTx30 (PVC/PVdC-Alu Blister PACKS)
|
|
5,42 |
6,23 |
8,59 |
Mylan Healthcare Ireland Ltd
|
31028.01.05
|
SERTRALINE/MYLAN F.C.TAB 50MG/TAB BTx30 (PVC/PVdC-Alu Blister PACKS)
|
|
4,96 |
5,70 |
7,85 |
Mylan Healthcare Ireland Ltd
|
31193.01.04
|
SEVELAMER/MYLAN F.C.TAB 800MG/TAB BTx1 HDPE BOTTLE x 180
|
|
45,27 |
52,04 |
66,20 |
Mylan Healthcare Ireland Ltd
|
31042.01.17
|
SIMVASTATIN/MYLAN F.C.TAB 10MG/TAB BT x 30 (σε blisters AL/PVC/PVDC) (σε blisters AL/PVC/PVDC)
|
|
1,15 |
1,32 |
1,82 |
Mylan Healthcare Ireland Ltd
|
31042.02.17
|
SIMVASTATIN/MYLAN F.C.TAB 20MG/TAB BTx30(BLISTERS AL/PVC/PVdC) AL/PVC/PVdC)
|
|
4,27 |
4,91 |
6,76 |
Mylan Healthcare Ireland Ltd
|
31042.03.17
|
SIMVASTATIN/MYLAN F.C.TAB 40MG/TAB BTx30 (BLISTERS ΑL/PVC/PVdC) ΑL/PVC/PVdC)
|
|
4,98 |
5,73 |
7,90 |
Mylan Healthcare Ireland Ltd
|
33011.02.05
|
SITAGLIPTIN+METFORMIN HYDROCHLORIDE MYLAN F.C.TAB (50+1000)MG/TAB 56 X 1 TAB - ΜΟΝΑΔΑ ΔΟΣΗΣ - ΣΕ BLISTERS (PVC/PE/PVDC/ALU)
|
|
12,34 |
14,18 |
19,54 |
Mylan Healthcare Ireland Ltd
|
33011.02.06
|
SITAGLIPTIN+METFORMIN HYDROCHLORIDE MYLAN F.C.TAB (50+1000)MG/TAB 60 X 1 TAB - ΜΟΝΑΔΑ ΔΟΣΗΣ - ΣΕ BLISTERS (PVC/PE/PVDC/ALU)
|
|
13,22 |
15,20 |
20,95 |
Mylan Healthcare Ireland Ltd
|
33011.01.05
|
SITAGLIPTIN+METFORMIN HYDROCHLORIDE MYLAN F.C.TAB (50+850)MG/TAB 56 X 1 TAB - ΜΟΝΑΔΑ ΔΟΣΗΣ - ΣΕ BLISTERS (PVC/PE/PVDC/ALU)
|
|
16,51 |
18,98 |
26,15 |
Mylan Healthcare Ireland Ltd
|
33011.01.06
|
SITAGLIPTIN+METFORMIN HYDROCHLORIDE MYLAN F.C.TAB (50+850)MG/TAB 60 X 1 TAB - ΜΟΝΑΔΑ ΔΟΣΗΣ - ΣΕ BLISTERS (PVC/PE/PVDC/ALU)
|
|
17,69 |
20,33 |
28,02 |
Mylan Healthcare Ireland Ltd
|
32315.03.02
|
SITAGLIPTIN/MYLAN F.C.TAB 100MG/TAB BT X 28 F.C.TABS ΣΕ BLISTER OPA/ALU/PVC//ALU
|
|
11,52 |
13,24 |
18,24 |
Mylan Healthcare Ireland Ltd
|
32315.02.02
|
SITAGLIPTIN/MYLAN F.C.TAB 50MG/TAB BT X 28 F.C.TABS ΣΕ BLISTER OPA/ALU/PVC//ALU
|
|
9,41 |
10,82 |
14,91 |
Mylan Healthcare Ireland Ltd
|
31026.02.03
|
SOTALOL/MYLAN TAB 160MG/TAB ΒΤx30 (BLISTERS)
|
|
2,85 |
3,27 |
4,51 |
Mylan Healthcare Ireland Ltd
|
31026.01.03
|
SOTALOL/MYLAN TAB 80MG/TAB ΒΤx30 (BLISTERS)
|
|
1,91 |
2,19 |
3,03 |
Mylan Healthcare Ireland Ltd
|
32944.01.02
|
SUGAMMADEX MYLAN INJ.SOL 100MG/ML 10 VIALS X 2 ML
|
|
412,29 |
458,56 |
529,82 |
Mylan Healthcare Ireland Ltd
|
32944.01.04
|
SUGAMMADEX MYLAN INJ.SOL 100MG/ML 10 VIALS X 5 ML
|
|
1.051,78 |
1.169,80 |
1.301,99 |
Mylan Healthcare Ireland Ltd
|
31016.01.03
|
TAMSULOSIN/MYLAN MOD.R.CA.H 0,4MG/CAP ΒΤ x 20 σε BLISTERS (PVC/PE/PVDC/AL) σε BLISTERS (PVC/PE/PVDC/AL)
|
|
2,52 |
2,90 |
4,00 |
Mylan Healthcare Ireland Ltd
|
31646.01.01
|
TIOTROPIUM/MYLAN INHPD.CAP 18MCG/CAP BTx30 caps σε blisters (ALU/ALU/PVC)+ 1 συσκευή NeumoHaler
|
|
12,63 |
14,52 |
20,01 |
Mylan Healthcare Ireland Ltd
|
31023.02.07
|
VENLAFAXINE/MYLAN PR.CAP 150MG/CAP BTx30 (PVC/PE/PVDC/Aluminium foil blister)
|
|
5,00 |
5,75 |
7,93 |
Mylan Healthcare Ireland Ltd
|